RxDoctor Payments Data

John Germiller

Otolaryngology · Philadelphia, PANPI 1104916121

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,444 of the $5,656 with a category attached, or 96.2%. Lilly USA, LLC accounts for 96.2% of it on its own, with 1 other manufacturer making up the rest.

$5,656in general payments, 2019–2025

Across 8 payments — averaging $707.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$5K
  • Eli Lilly$212
$819,832in research payments, 2019–2025

Across 45 payments — averaging $18,218 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$486K
  • Cochlear Americas$328K
  • Upjohn US 1 LLC$6K

What the payments were for

  • Consulting fees$5,44496%
  • Travel & lodging$1082%
  • Food & beverage$1042%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC5$5,444
Eli Lilly3$212

How this compares

$5,656 in reported general payments places this provider in the 85th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania →

Other otolaryngology in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →